Use of Typhoid Vi-Polysaccharide Vaccine as a Vaccine Probe to Delineate Clinical Criteria for Typhoid Fever-Reference-Cited by-同舟云学术

Use of Typhoid Vi-Polysaccharide Vaccine as a Vaccine Probe to Delineate Clinical Criteria for Typhoid Fever

Published:2020-08-05 Issue:2 Volume:103 Page:665-671
ISSN:0002-9637
Container-title:The American Journal of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Islam Md. Taufiqul¹,Im Justin²,Ahmmed Faisal¹,Kim Deok Ryun²,Khan Ashraful Islam¹,Zaman Khalequ¹,Ali Mohammad³,Marks Florian⁴²,Qadri Firdausi¹,Kim Jerome H.²,Clemens John D.⁵⁶¹

Affiliation:

1. International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh;

2. International Vaccine Institute, Seoul, Republic of Korea;

3. Johns Hopkins University, Baltimore, Maryland;

4. Department of Medicine, University of Cambridge, Cambridge, United Kingdom;

5. Korea University College of Medicine, Seoul, South Korea

6. UCLA Fielding School of Public Health, Los Angeles, California;

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Reference53 articles.

1. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017;Lancet Infect Dis,2019

2. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010;Buckle;J Global Health,2012

3. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections;Crump;Clin Microbiol Rev,2015

4. The global burden of typhoid fever;Crump;Bull World Health Organ,2004

5. The relationship between blood sample volume and diagnostic sensitivity of blood culture for typhoid and paratyphoid fever: a systematic review and meta-analysis;Antillon;J Infect Dis,2018